Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-02 Sale |
2021-12-03 5:20 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
17,500 | $20.18 | $353,150 | 255,996 (Direct) |
View |
| 2021-11-03 Sale |
2021-11-05 4:17 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
25,000 | $24.28 | $607,123 | 195,510 (Indirect Direct) |
View |
| 2021-11-02 Sale |
2021-11-03 4:16 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
17,500 | $22.57 | $394,975 | 273,496 (Direct) |
View |
| 2021-11-01 Sale |
2021-11-03 4:15 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
6,500 | $22.24 | $144,560 | 330,606 (Direct) |
View |
| 2021-10-15 Sale |
2021-10-18 4:21 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
12,500 | $21.59 | $269,826 | 120,921 (Direct) |
View |
| 2021-10-04 Sale |
2021-10-05 4:11 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
17,500 | $21.54 | $376,950 | 290,996 (Direct) |
View |
| 2021-10-01 Sale |
2021-10-05 4:10 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
6,500 | $22.06 | $143,367 | 337,106 (Direct) |
View |
| 2021-09-15 Sale |
2021-09-17 4:05 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
12,500 | $24.69 | $308,605 | 133,421 (Direct) |
View |
| 2021-09-01 Sale |
2021-09-03 4:38 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
12,500 | $24.04 | $300,500 | 220,510 (Indirect Direct) |
View |
| 2021-09-01 Sale |
2021-09-03 4:38 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
8,559 | $24 | $205,416 | 343,606 (Direct) |
View |
| 2021-09-02 Sale |
2021-09-03 4:37 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
17,500 | $23.89 | $418,075 | 308,496 (Direct) |
View |
| 2021-08-16 Sale |
2021-08-17 9:15 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
10,000 | $18.79 | $187,900 | 145,921 (Direct) |
View |
| 2021-08-02 Sale |
2021-08-04 5:39 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
4,441 | $22.03 | $97,835 | 352,165 (Direct) |
View |
| 2021-08-03 Sale |
2021-08-04 5:38 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
17,500 | $20.83 | $364,577 | 325,996 (Direct) |
View |
| 2021-07-15 Sale |
2021-07-19 4:43 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
10,000 | $20.9 | $209,044 | 155,921 (Direct) |
View |
| 2021-07-06 Sale |
2021-07-08 7:19 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
6,500 | $24.52 | $159,380 | 356,606 (Direct) |
View |
| 2021-07-02 Sale |
2021-07-06 5:52 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
17,500 | $24.78 | $433,650 | 342,489 (Direct) |
View |
| 2021-06-01 Sale |
2021-06-03 8:07 pm |
Akero Therapeutics Inc. | AKRO | Bitterman Kevin Director |
17,489 | $26.28 | $459,611 | 2,232,251 (Indirect) |
View |
| 2021-06-01 Sale |
2021-06-02 4:06 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
3,055 | $26.24 | $80,151 | 224,010 (Indirect Direct) |
View |
| 2021-05-03 Sale |
2021-05-04 4:06 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
3,055 | $30.56 | $93,361 | 227,065 (Indirect Direct) |
View |
| 2021-05-03 Sale |
2021-05-04 4:06 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
4,200 | $30.56 | $128,352 | 362,099 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-12-08 Option Award |
2021-12-10 5:15 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
261,662 | $0 | 261,662 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-10 5:08 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
87,221 | $0 | 87,221 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-10 5:08 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
87,221 | $0 | 87,221 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-10 5:07 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
87,221 | $0 | 87,221 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-10 5:06 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
87,221 | $0 | 87,221 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-03 4:15 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
6,500 | $7.009 | 330,606 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-03 4:15 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
6,500 | $0 | 330,606 (Direct) |
View |
| 2021-10-01 Exercise |
2021-10-05 4:10 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
6,500 | $7.009 | 337,106 (Direct) |
View |
| 2021-10-01 Exercise |
2021-10-05 4:10 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
6,500 | $0 | 337,106 (Direct) |
View |
| 2021-09-01 Exercise |
2021-09-03 4:38 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
8,559 | $7.009 | 343,606 (Direct) |
View |
| 2021-09-01 Exercise |
2021-09-03 4:38 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
8,559 | $0 | 343,606 (Direct) |
View |
| 2021-08-02 Exercise |
2021-08-04 5:39 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
4,441 | $7.009 | 352,165 (Direct) |
View |
| 2021-08-02 Exercise |
2021-08-04 5:39 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
4,441 | $0 | 352,165 (Direct) |
View |
| 2021-07-15 Exercise |
2021-07-19 4:43 pm |
N/A 2028-07-29 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
9,000 | $0 | 259,306 (Direct) |
View |
| 2021-07-15 Exercise |
2021-07-19 4:43 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
9,000 | $0.615 | 259,306 (Direct) |
View |
| 2021-07-12 Option Award |
2021-07-14 4:09 pm |
N/A 2031-07-12 |
Akero Therapeutics Inc. | AKRO | Judy Chou Director |
26,000 | $0 | 26,000 (Direct) |
View |
| 2021-07-06 Exercise |
2021-07-08 7:19 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
6,500 | $7.009 | 356,606 (Direct) |
View |
| 2021-07-06 Exercise |
2021-07-08 7:19 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
6,500 | $0 | 356,606 (Direct) |
View |
| 2021-06-28 Other |
2021-06-30 4:31 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | ATP Life Science Ventures L.P. ATP III GP Ltd. 10% Owner |
5,830,203 | $0 | 5,830,203 (Direct) |
View |
Ownership |
2021-06-30 4:16 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Skorpios Trust Blue Horizon Enterprise Ltd Ezbon International Ltd Montrago Trustees Ltd 10% Owner |
0 | $0 | 4,907,829 (Indirect) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:59 pm |
N/A 2031-05-31 |
Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:58 pm |
N/A 2031-05-31 |
Akero Therapeutics Inc. | AKRO | Iwicki Mark T Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:58 pm |
N/A 2031-05-31 |
Akero Therapeutics Inc. | AKRO | Henderson Jane Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:57 pm |
N/A 2031-05-31 |
Akero Therapeutics Inc. | AKRO | Xu Yuan Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:56 pm |
N/A 2031-05-31 |
Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:56 pm |
N/A 2031-05-31 |
Akero Therapeutics Inc. | AKRO | Bitterman Kevin Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:55 pm |
N/A 2031-05-31 |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
13,000 | $0 | 62,832 (Direct) |
View |
| 2021-06-01 Gift |
2021-06-03 5:55 pm |
N/A 2031-05-31 |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
49,832 | $0 | 62,832 (Direct) |
View |
| 2021-05-03 Exercise |
2021-05-04 4:06 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
4,200 | $7.009 | 362,099 (Direct) |
View |
| 2021-05-03 Exercise |
2021-05-04 4:06 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
4,200 | $0 | 362,099 (Direct) |
View |
| 2021-04-22 Option Award |
2021-04-26 5:09 pm |
N/A 2031-04-22 |
Akero Therapeutics Inc. | AKRO | Xu Yuan Director |
26,000 | $0 | 26,000 (Direct) |
View |